Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biodyne, Inc. was a pharmaceutical company primarily known for the development and commercialization of Live Yeast Cell Derivative (LYCD), a biological substance marketed under the trade name Biodyne. The company's core product was derived from the cellular contents of yeast and was clinically utilized to stimulate cellular respiration and accelerate wound healing. Biodyne (LYCD) became a widely recognized active ingredient in topical treatments, most notably in the original formulation of Preparation H, where it was used to promote tissue repair. The company was historically associated with the Sperti Drug Company and focused on the therapeutic applications of skin respiratory factors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biodyne Pharmaceuticals.